Company / Gross Margin
NovoCure Ltd Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
74.5%
FY2025
5-year range
74.5% / 78.6%
FY2021-FY2025
Trend
-3.6%
vs FY2024
Sector context
#12 of 91
Health Care
What the data says
NovoCure Ltd's gross margin of 74.5% is higher than 87% of companies in the Health Care sector (FY2025). Gross Margin has fluctuated over the past 10 years, ranging from 44.2% in FY2016 to 78.6% in FY2022.
Based on SEC 10-K filings.
74.5% in FY2025 with a 5-year CAGR of -3.9%. Top quartile in the Health Care sector.
Remained stable around 74.5% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -4.1pp
- 5-Year Change
- -3.9pp
- 10-Year Change
- -
Sector benchmark
Top 13% in Health CareTop 13% of 91This company 74.5% Sector average 53.8%
▼
+38.6% above sector average
Key checks
Key Insights
- In FY2025, gross margin decreased 3.6% year-over-year.
- Currently 20.7pp above the Health Care sector average.
- Peak gross margin was recorded in FY2022.
- Lowest gross margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 74.5% | -3.6% |
| FY2024 | 77.3% | +3.4% |
| FY2023 | 74.8% | -4.9% |
| FY2022 | 78.6% | +0.1% |
| FY2021 | 78.5% | +0.1% |
| FY2020 | 78.5% | +4.9% |
| FY2019 | 74.8% | +10.4% |
| FY2018 | 67.7% | -1.3% |
| FY2017 | 68.6% | +55.3% |
| FY2016 | 44.2% | +17.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026